| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |